These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12488664)

  • 21. Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.
    Bennish ML; Salam MA; Haider R; Barza M
    J Infect Dis; 1990 Sep; 162(3):711-6. PubMed ID: 2201742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics for the treatment of dysentery in children.
    Traa BS; Walker CL; Munos M; Black RE
    Int J Epidemiol; 2010 Apr; 39 Suppl 1(Suppl 1):i70-4. PubMed ID: 20348130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and outcome of Shigella encephalopathy in Bangladeshi children.
    Afroze F; Ahmed T; Sarmin M; Smsb Shahid A; Shahunja KM; Shahrin L; Chisti MJ
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005561. PubMed ID: 28453565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults.
    Salam MA; Seas C; Khan WA; Bennish ML
    Ann Intern Med; 1995 Oct; 123(7):505-8. PubMed ID: 7661494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of quinolone-resistant Shigella dysenteriae type 1 in Canada.
    Can Commun Dis Rep; 2005 Oct; 31(19):193-7. PubMed ID: 16200675
    [No Abstract]   [Full Text] [Related]  

  • 26. A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.
    Vinh H; Anh VT; Anh ND; Campbell JI; Hoang NV; Nga TV; Nhu NT; Minh PV; Thuy CT; Duy PT; Phuong le T; Loan HT; Chinh MT; Thao NT; Tham NT; Mong BL; Bay PV; Day JN; Dolecek C; Lan NP; Diep TS; Farrar JJ; Chau NV; Wolbers M; Baker S
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1264. PubMed ID: 21829747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial resistance profiles of Shigella dysenteriae isolated from travellers returning to the UK, 2004-2017.
    Terry LM; Barker CR; Day MR; Greig DR; Dallman TJ; Jenkins C
    J Med Microbiol; 2018 Aug; 67(8):1022-1030. PubMed ID: 29957175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An epidemic of bacillary dysentery caused by Shigella dysenteriae, type 1, in Mogadiscio].
    Nuti M; Harare OM; Mero E
    Ann Sclavo; 1977; 19(2):209-18. PubMed ID: 341817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for death in hospitalized dysentery patients in Rwanda.
    Legros D; Paquet C; Dorlencourt F; Saoult E
    Trop Med Int Health; 1999 Jun; 4(6):428-32. PubMed ID: 10444318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An outbreak of Shigella dysenteriae type 1 dysentery in a refugee camp in Rwanda].
    Paquet C; Leborgne P; Sasse A; Varaine F
    Sante; 1995; 5(3):181-4. PubMed ID: 7640901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemic shigella dysentery in children in northern KwaZulu-Natal.
    Chopra M; Wilkinson D; Stirling S
    S Afr Med J; 1997 Jan; 87(1):48-51. PubMed ID: 9063314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
    Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
    JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia.
    Talukder KA; Khajanchi BK; Islam MA; Dutta DK; Islam Z; Safa A; Khan GY; Alam K; Hossain MA; Malla S; Niyogi SK; Rahman M; Watanabe H; Nair GB; Sack DA
    J Antimicrob Chemother; 2004 Oct; 54(4):730-4. PubMed ID: 15347639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
    Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q
    BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing antibiotic sensitivity patterns in shigellosis.
    Lamabadusuriya SP; Devasiri IV; Jayantha UK; Perera C
    Ceylon Med J; 1991 Dec; 36(4):159-61. PubMed ID: 1807844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shigella dysenteriae serotype 1 in west Africa: intervention strategy for an outbreak in Sierra Leone.
    Guerin PJ; Brasher C; Baron E; Mic D; Grimont F; Ryan M; Aavitsland P; Legros D
    Lancet; 2003 Aug; 362(9385):705-6. PubMed ID: 12957094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imported shiga dysentery.
    Moss PD; Darling WM
    Lancet; 1977 Oct; 2(8041):772. PubMed ID: 71589
    [No Abstract]   [Full Text] [Related]  

  • 39. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones.
    Sarkar K; Ghosh S; Niyogi SK; Bhattacharya SK
    Lancet; 2003 Mar; 361(9359):785. PubMed ID: 12620764
    [No Abstract]   [Full Text] [Related]  

  • 40. Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.
    Haltalin KC; Nelson JD; Ring R; Sladoje M; Hinton LV
    J Pediatr; 1967 Jun; 70(6):970-81. PubMed ID: 5338090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.